Pune's Remidio wins Anjani Mashelkar Award for 75-second, Rs 100 AI retinal screening
Images are not validated/verified
Remidio's portable, non-invasive retina imaging technology, which uses AI to screen for eye and systemic diseases, has been honoured with the Anjani Mashelkar Award 2026.
Pune, November 17, 2026: Pune-based company Remidio has been honoured with the Anjani Mashelkar Award 2026. The award recognises its portable, non-invasive retinal imaging technology, which uses artificial intelligence (AI) to screen for several eye and body diseases.
The award was presented at the 14th National Social Innovation Conference of the Pune International Centre (PIC). Kiran Karnik, chairperson of HelpAge India and former president of Nasscom, was present at the ceremony. Dr R. A. Mashelkar, chairman of the Anjani Mashelkar Foundation and president of PIC, and Dr Vijay Kelkar, vice-president of PIC, also attended. Remidio founder Dr Anand Sivaraman received the award on behalf of the company.
According to the company, the technology scans the retina in about 75 seconds at a cost of roughly Rs 100. The company says the platform can screen for 10 conditions, including diabetic retinopathy, glaucoma and age-related eye degeneration. It is also said to screen for diabetes, high blood pressure, heart disease, chronic kidney disease, anaemia, pregnancy-related risks and gestational diabetes.
The technology runs on offline AI, so it does not need an internet connection, a laboratory or an ophthalmologist at the screening site. It aims to make early screening easier in communities where specialist doctors, diagnostic facilities and affordable tests are still scarce.
The technology is designed so that frontline health workers can screen the retina. The screening can be done at primary health centres, vision centres, outreach camps and mobile clinics, including facilities in remote locations. The company said its Remidio Connect platform links retinal scans to patient records, AI-generated reports, referral and follow-up services. The aim is to help healthcare providers identify people who may need further medical tests and to keep treatment continuous.
On receiving the award, Dr Sivaraman said: "We are truly proud to receive the Anjani Mashelkar Award. Dr Mashelkar's mantra of 'more from less for more people' has been our guide. We are now moving towards making the eye a window to everyone's overall health. The time has come for India to become a product nation."
Speaking on the significance of the innovation, Dr R. A. Mashelkar said: "This portable and non-invasive platform from Remidio shows that the eye has the power to detect life-threatening diseases. It opens up possibilities of making healthcare a basic human right for all underserved people in India and across the world."
According to the company, Remidio's technology has received 12 regulatory approvals, including an FDA listing. Its devices are installed at more than 4,000 sites or units in over 55 countries. The company says more than 1.6 crore patients have been screened worldwide.
Bill Gates also mentioned the technology in an article he wrote in April 2026. The article discussed efforts to prevent stillbirths and the role of technology in reaching areas lacking maternal health services. Of this technology, Gates said: "When we see a clever thing like this, that is our biggest goal, which is saving lives."
Reach readers on the ward they actually live in.
Advertise with Prime Time 24Reach readers on the ward they actually live in.
Advertise with Prime Time 24Reach readers on the ward they actually live in.
Advertise with Prime Time 24Choose primetime24.com as a preferred source on Google Google shows more stories from your preferred sources in Top Stories.
Reach readers on the ward they actually live in.
Advertise with Prime Time 24
Comments
No comments yet. Be the first.